Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) Stock Price, Quote & AI Analysis
Live LIXT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Lixte Biotechnology Holdings, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Lixte Biotechnology Holdings, Inc. Common Stock (LIXT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Lixte Biotechnology Holdings, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Lixte Biotechnology Holdings, Inc. Common Stock Overview
Company information
Company Overview
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Lixte Biotechnology Holdings, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...